CE Holdings Co.,Ltd. (4320.T)
- Previous Close
651.00 - Open
652.00 - Bid 639.00 x --
- Ask 642.00 x --
- Day's Range
632.00 - 652.00 - 52 Week Range
355.00 - 714.00 - Volume
52,000 - Avg. Volume
90,268 - Market Cap (intraday)
10.248B - Beta (5Y Monthly) 0.42
- PE Ratio (TTM)
21.78 - EPS (TTM)
29.38 - Earnings Date Aug 7, 2025 - Aug 11, 2025
- Forward Dividend & Yield 40.00 (6.14%)
- Ex-Dividend Date Sep 29, 2025
- 1y Target Est
--
CE Holdings Co.,Ltd., through its subsidiaries, develops and sells electronic medical record systems and medical information systems in Japan. The company develops MI RA Is, an electronic medical record system and consignment system; develops, implements, operates, and maintains nursing work systems; offers clinical development support services using imaging technology; and dispatches skilled human resources for clinical development. It also provides industrial health, human resource, and marketing services; and offers digital marketing implementation support and digital marketing human resource development services. The company was formerly known as CEI Corporation and changed its name to CE Holdings Co., Ltd. in April 2013. CE Holdings Co.,Ltd. was incorporated in 1996 and is headquartered in Sapporo, Japan.
www.ce-hd.co.jp606
Full Time Employees
September 30
Fiscal Year Ends
Sector
Industry
Recent News: 4320.T
View MorePerformance Overview: 4320.T
Trailing total returns as of 6/13/2025, which may include dividends or other distributions. Benchmark is Nikkei 225 (^N225) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 4320.T
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 4320.T
View MoreValuation Measures
Market Cap
10.07B
Enterprise Value
8.02B
Trailing P/E
21.40
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.64
Price/Book (mrq)
1.46
Enterprise Value/Revenue
0.51
Enterprise Value/EBITDA
4.14
Financial Highlights
Profitability and Income Statement
Profit Margin
2.93%
Return on Assets (ttm)
8.01%
Return on Equity (ttm)
7.99%
Revenue (ttm)
15.68B
Net Income Avi to Common (ttm)
459M
Diluted EPS (ttm)
29.38
Balance Sheet and Cash Flow
Total Cash (mrq)
3.85B
Total Debt/Equity (mrq)
24.26%
Levered Free Cash Flow (ttm)
1.33B